Patient information was then classified into the following categories: year, author, age at diagnosis, age at onset of symptoms, gender, type of tumor, location of primary tumor, metastases, acid-base disorders, hydroelectrolyte disorders, MYCN expression, serum VIP level, treatment performed, and outcome, whenever the information was available. This evidence concerns the gene VIP and neoplasm.